A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies
NCT07887867
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatitis, Atopic
Interventions
DRUG:
abrocitinib
Sponsor
Pfizer